Cargando…
Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial
BACKGROUND: China's three inactivated enterovirus A71 (EV-A71) vaccines are the first and currently world's only EV-A71 vaccines approved by a national regulatory authority and used to prevent EV-A71 associated diseases. The three vaccines vary by vaccine strain, manufacturing cell substra...
Autores principales: | Li, Yan, Gao, Fan, Wang, Yamin, Li, Jing, Zhang, Yuxi, Lv, Huakun, Wang, Shenyu, Yang, Haitao, Liu, Xiaoqiang, Li, Keli, Wang, Huaqing, Yin, Zundong, Liang, Zhenglun, An, Zhijie, Mao, Qunying, Feng, Zijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8579145/ https://www.ncbi.nlm.nih.gov/pubmed/34881371 http://dx.doi.org/10.1016/j.lanwpc.2021.100284 |
Ejemplares similares
-
Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China
por: Wang, Xiaoli, et al.
Publicado: (2019) -
EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
por: Mao, Qunying, et al.
Publicado: (2016) -
Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial
por: Tong, Yeqing, et al.
Publicado: (2022) -
The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children
por: Mao, Qunying, et al.
Publicado: (2013) -
Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Chronic Obstructive Pulmonary Disease — Hebei Province, China, September−December, 2019
por: Li, Yan, et al.
Publicado: (2021)